BERKELEY HEIGHTS, N.J., Jan. 6, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (“Cyclacel” or the “Company”) today announced that Spiro Rombotis, President and Chief Executive Officer, will review the Company’s 2011 achievements and key clinical development and business objectives for 2012 at the 5th Annual OneMedForum San Francisco 2012 at 9:15 am Pacific Time on Wednesday, January 11, 2012.
